
Scientists at Johns Hopkins Medicine have made progress towards developing an effective HIV vaccine. Using a laboratory technique called reductionist cell-free antigen processing, the researchers replicated the cellular environment where specialized immune cells called antigen-presenting cells (APCs) break down proteins derived from HIV. By identifying immunodominant epitopes that elicit a strong immune response, they hope to create an effective HIV vaccine. Previous methods for mapping these epitopes have proven unreliable, but the new technique allows for a more accurate representation of how epitopes are processed in the APCs' cellular environment. The findings also revealed previously unknown epitopes, offering potential insights for vaccine development against HIV and other viral pathogens.
Like
Save
Share